Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
LGSOC
.
Show all posts
Showing posts with label
LGSOC
.
Show all posts
Monday, July 8, 2013
Array BioPharma achieves milestone for initiation of MEK162 Phase 3 trial in patients with LGSOC
›
We know that, MEK162 , is an oral, highly selective MEK inhibitor. In preclinical studies, MEK162 showed significant antitumor ...
›
Home
View web version
